nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bone marrow-derived cells are recruited by the melanoma tumor with endothelial cells contributing to tumor vasculature
|
Bonfim-Silva, R. |
|
2016 |
19 |
1 |
p. 125-133 |
artikel |
2 |
CT scan prior to radiotherapy in unresectable, locally advanced, non-small cell carcinoma of the lung: is it always necessary?
|
Calvo Temprano, D. |
|
2016 |
19 |
1 |
p. 105-110 |
artikel |
3 |
Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma
|
Kauttu, T. |
|
2016 |
19 |
1 |
p. 58-66 |
artikel |
4 |
Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer
|
Franco, P. |
|
2016 |
19 |
1 |
p. 67-75 |
artikel |
5 |
Downregulated ECRG4 is correlated with lymph node metastasis and predicts poor outcome for nasopharyngeal carcinoma patients
|
Chen, J.-Y. |
|
2016 |
19 |
1 |
p. 84-90 |
artikel |
6 |
Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study
|
Gavila, J. |
|
2016 |
19 |
1 |
p. 91-104 |
artikel |
7 |
Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab
|
Hilario, A. |
|
2016 |
19 |
1 |
p. 51-57 |
artikel |
8 |
Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials?
|
Cataldo, A. Di |
|
2016 |
19 |
1 |
p. 76-83 |
artikel |
9 |
Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments
|
Zarzosa, P. |
|
2016 |
19 |
1 |
p. 44-50 |
artikel |
10 |
Safety and efficacy of primary thromboprophylaxis in cancer patients
|
García Escobar, I. |
|
2016 |
19 |
1 |
p. 1-11 |
artikel |
11 |
Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma
|
Aya, F. |
|
2016 |
19 |
1 |
p. 119-124 |
artikel |
12 |
Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma
|
Jiménez-Fonseca, P. |
|
2016 |
19 |
1 |
p. 12-20 |
artikel |
13 |
Targeted cancer therapy: interactions with other medicines
|
Conde-Estévez, D. |
|
2016 |
19 |
1 |
p. 21-30 |
artikel |
14 |
Targeted therapy combined with radiotherapy in non-small-cell lung cancer: a review of the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
|
Couñago, F. |
|
2016 |
19 |
1 |
p. 31-43 |
artikel |
15 |
Utility of 18F-FDG-PET/CT in patients suspected of paraneoplastic neurological syndrome: importance of risk classification
|
Pena Pardo, F. J. |
|
2016 |
19 |
1 |
p. 111-118 |
artikel |